Equities researchers at Cantor Fitzgerald started coverage on shares of Welltower (NYSE:WELL – Get Free Report) in a report issued on Wednesday, MarketBeat.com reports. The firm set an “overweight” rating and a $195.00 price target on the real estate investment trust’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 11.02% from the stock’s previous close.
Other analysts also recently issued research reports about the company. Wells Fargo & Company upped their price target on Welltower from $175.00 to $185.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. Raymond James Financial reiterated a “strong-buy” rating on shares of Welltower in a research note on Tuesday, September 2nd. UBS Group started coverage on Welltower in a research note on Friday, September 19th. They set a “buy” rating and a $195.00 target price on the stock. Scotiabank increased their target price on Welltower from $172.00 to $181.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Finally, Evercore ISI increased their target price on Welltower from $175.00 to $183.00 and gave the company an “in-line” rating in a research note on Monday, September 15th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $180.62.
Check Out Our Latest Stock Report on Welltower
Welltower Stock Down 2.1%
Welltower (NYSE:WELL – Get Free Report) last posted its quarterly earnings results on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.06. The company had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.49 billion. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The firm’s quarterly revenue was up 39.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.05 EPS. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. As a group, analysts forecast that Welltower will post 4.88 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Welltower
A number of institutional investors have recently bought and sold shares of WELL. Brighton Jones LLC raised its holdings in Welltower by 7.1% in the 4th quarter. Brighton Jones LLC now owns 4,185 shares of the real estate investment trust’s stock worth $527,000 after purchasing an additional 279 shares during the period. Versant Capital Management Inc raised its holdings in Welltower by 27.0% during the first quarter. Versant Capital Management Inc now owns 381 shares of the real estate investment trust’s stock valued at $58,000 after acquiring an additional 81 shares during the period. NBC Securities Inc. bought a new stake in Welltower during the first quarter valued at about $131,000. Merit Financial Group LLC raised its holdings in Welltower by 3.0% during the first quarter. Merit Financial Group LLC now owns 25,286 shares of the real estate investment trust’s stock valued at $3,874,000 after acquiring an additional 729 shares during the period. Finally, Apella Capital LLC raised its holdings in Welltower by 5.9% during the first quarter. Apella Capital LLC now owns 2,016 shares of the real estate investment trust’s stock valued at $285,000 after acquiring an additional 112 shares during the period. 94.80% of the stock is owned by institutional investors.
Welltower Company Profile
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
See Also
- Five stocks we like better than Welltower
- How to buy stock: A step-by-step guide for beginners
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Stock Analyst Ratings and Canadian Analyst Ratings
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.